Effects of Above-Ankle Orthoses on Individuals with Diabetic Partial Foot by Ewers, Susan
EFFECTS OF ABOVE-ANKLE ORTHOSES ON INDIVIDUALS WITH DIABETIC
 
PARTIAL FOOT AMPUTATION
 
by
 
SUSAN EWERS
 
A THESIS
 
Presented to the Department of Human Physiology
 
and the Graduate School of the University of Oregon
 
in partial fulfillment of the requirements
 
for the degree of
 
Master of Science
 
December 2007
 
Li-Shan Chou, Chair of the Examining Committee
Date
Committee in Charge:	 Li-Shan Chou, Chair
Lou Osternig
Accepted by:
"Effects of Above-Ankle Orthoses on Individuals with Diabetic Partial Foot
Amputation," a thesis prepared by Susan Ewers in partial fulfillment of the requirements
for the Master of Science degree in the Department of Human Physiology. This thesis has
been approved and accepted by:
Dean of the Graduate School
11l 
© 2007 Susan Ewers 
iv
An Abstract of the Thesis of
Susan Ewers	 for the degree of	 Master of Science
in the Department of Human Physiology 	 to be taken	 December 2007
Title: EFFECTS OF ABOVE-ANKLE ORTHOSES ON INDIVIDUALS WITH
DIABETIC PARTIAL FOOT AMPUTATION
Approved: 
	
	
Li-Shan Chou
Partial foot amputation is becoming more prevalent and costly and if not treated
correctly can lead to higher levels of amputation. Despite this, partial foot orthotic
research and development has been inadequate. Furthermore, in order to contribute to
improved orthotic management, there is a need to understand the biomechanical
discrepancies during gait.
Biomechanical goals of orthotic fitting include normalizing the three functional
impairments of the transmetatarsal amputee. The first goal is to improve balance, the
second is to normalize the toe-off phase of gait, and the third goal involves supporting the
plantar surface of the foot to evenly distribute pressure.
In this study, all subjects were evaluated with a below-ankle condition and an
above-ankle condition. The below-ankle condition consisted of a total contact foot
orthosis fitted into Drew' shoes with rocker bottom soles. The below-ankle orthosis was
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then fitted with a Blue Rocker© ankle foot orthosis and gait was re-evaluated as the 
above-ankle orthotic gait condition. 
Three specific goals were proposed in this study: 1) to determine the differing, if 
any, effects on balance and vertical ground reaction symmetry during level walking and 
obstacle crossing between the two orthotic designs, 2) to determine the plantar pressure 
distribution differences between a below-ankle and an above-ankle design, 3) to learn 
about patient preferences to provide realistic feedback for quality patient care. We 
hypothesized that improved balance, symmetry and distribution of pressure would occur 
with the above-ankle design in individuals with greater disability. 
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CHAPTER I 
INTRODUCTION 
Partial foot amputations may result from trauma, peripheral vascular disease 
(PVD), tumors, or, the number one cause in the United States, diabetes complicated by 
neuropathic disease (ND). In 2002, for every 1000 people with diabetes 2.6 underwent 
toe amputations and 0.8 underwent foot amputations (2). The number of amputations 
continues to grow as diabetes becomes more prevalent. In 2005, 1.5 million new cases of 
diabetes were diagnosed in people 20 years and older. The prevalence of partial foot 
amputation is also increasing due to new surgical techniques which encourage a partial 
foot level of amputation rather than a more proximal transtibiallevel (3, 4). Partial foot 
amputation may include any part of the foot, from part ofa toe to all of the foot excluding 
part of the calcaneus. The effects on the biomechanical ability of the individual and the 
possibility for further complications vary depending on the level of the amputation. 
Therefore, this study will concentrate on the transmetatarsallevel of amputation. 
Transmetatarsal amputation (TMA) involves removal ofthe metatarsal heads 
resulting in the loss of normal forefoot weight bearing (Figure 1). This leads to a 
decreased lever arm for push-off and a reduction in the degree of forefoot pronation and 
supination which helps with ambulation on uneven surfaces. Furthermore, the resection 
of the first metatarsal head disrupts the medial longitudinal arch. This affects the 
mediolateral alignment of the plantar surface of the foot because an unsupported first ray 
will place the foot in a pronated position upon weight bearing (5) (6). Removal of the 
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Classical llJJ1pUlalioJl levels 
Figure 1. Levels of TMA 
2-Distal Transmetatarsal 
3-Proximal Transmetatarsal 
forefoot results in the loss of four extrinsic muscles, all the intrinsic muscles and the 
plantar fascia leading to compensatory biomechanics as the foot contacts the ground (7). 
Each patient presents unique morphologic characteristics due to the variety of surgical 
techniques and the patient's pre-operative condition. 
There are several advantages associated with this level of amputation. 
Maintaining a long lever, as compared to the transtibiallevel of amputation, is always 
advantageous when dealing with forces, such as pressure distribution and moment arms. 
Allowing for distal weight bearing is an advantage because it provides some 
independence from the orthosis (for instance at night). Maintaining ankle motion is 
thought to be of benefit to the amputee, although this is somewhat controversial. We 
could speculate that this level of amputation could also lead to less compensatory action 
ofthe uninvolved limb because the body weight can be shared more equally between the 
two feet than would be possible with a higher level of amputation. In order for this level 
of amputation to succeed interdisciplinary team communication, patient education and 
compliance, surgical technique, proper orthotic fitting, gait training, and substantial 
follow-up must be considered as all these factors affect patient outcomes. 
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Statement ofthe Problem - How Can We Better Aid Balance and Improve Symmetry? 
Important goals of prosthetic and orthotic fitting include decreasing further 
deformity, distributing pressure and restoring independence (8) to reduce the occurrence 
of ulceration and the likelihood of further amputation. Biomechanical goals of orthotic 
fitting include normalizing the three functional impairments of the transmetatarsal 
amputee. The first goal is to improve balance, the second involves supporting the plantar 
surface of the foot to maintain normal anatomical alignment, and the third goal is to 
normalize the toe-off phase of gait (6). 
Transmetatarsal orthoses vary in design and materials according to the patient's 
functional demands, degree of imbalance, alignment, strength, compliance and activity 
level. For example, some amputees may function well with a below-ankle design (Figure 
2) which allows full ankle motion, while others will require an above-ankle design 
(Figure 3 and 4) for increased balance and greater surface area for pressure distribution. 
Above-ankle designs look somewhat similar to an ankle foot orthosis (AFO) and mayor 
may not include ankle joints. 
ffI 
, ) 
Figure 2. Figure 3.	 Figure 4. 
Below-ankle orthosis Above-ankle orthosis	 Above-ankle
 
articulated orthosis
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With the use of the above ankle orthosis both the antero-posterior and medio-lateral ankle 
motions are expected to be diminished, theoretically providing a more stable base of 
support. This is more important for the individual with decreased muscle strength. The 
addition of ankle articulation allows for dorsi/plantarflexion of varying degrees, but 
limited medio-lateral motion at the ankle (Figure 4). Stopping dorsiflexion but allowing 
plantarflexion in mid-stance will result in a net extensor moment at the ankle and the 
knee, therefore corresponding with the requirements for support during stance (Figure 5, 
this figure does not illustrate well for the knee joint) (9). An ankle dorsiflexion stop 
during terminal stance should result in the transfer of force from the distal plantar surface 
of the stump to the anterior tibia, therefore reducing peak plantar pressures and the 
likelihood of skin breakdown (6). Another orthotic design includes a semi-flexible strut 
for resistance to plantarflexion, dorsiflexion, inversion and eversion motions (Figure 6). 
This is a more streamlined and lighter weight design than the ankle joint design but may 
have decreased durability depending on its fabrication. 
Figure 6. Figure 5. 
Semi-flexible Above­Moment Alteration 
Ankle Orthosis Due to GRF 
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Specific Aims 
Research question 1: How does the orthosis affect balance control during ambulation?
 
Hypothesis: The partial foot above-ankle orthosis with moderate resistance in sagittal
 
and frontal plane motion will assist ambulation by decreasing the magnitude ofthe
 
mediolateral sway of the whole body center of mass (COM) during gait.
 
Research question 2: How do the temporal-spatial parameters change between the
 
above-ankle and the below-ankle conditions?
 
Hypothesis: The improved rollover with the use of the above-ankle design will allow for
 
more equalized step length and less of a 'limp' as compared to the below-ankle design.
 
The step width might decrease with the use of the above-ankle design.
 
Research question 3: How does the above-ankle device affect the vertical ground
 
reaction forces between the involved and uninvolved limbs?
 
Hypothesis: The involved and uninvolved vertical ground reaction force curves will be
 
more symmetrical with the above-ankle as compared to the below-ankle condition.
 
Research question 4: Does the above-ankle design alter the distribution ofthe pressures
 
on the plantar surface ofthe foot as compared to the below-ankle design?
 
Hypothesis: During terminal stance the pressures on the partial foot amputee occur at the
 
distal-plantar aspect ofthe foot, i.e. at the location ofthe cut bones. The magnitude of
 
the plantar pressures with the above-ankle design may not alter as compared to the
 
below-ankle design.
 
Research question 5: Which device does the subject prefer to wear and why?
 
Hypothesis: The subject will prefer to wear the lightest weight and least bulky device.
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CHAPTER II 
REVIEW OF LITERATURE 
Function ofthe Transmetatarsal Amputee (FMA) Patient 
Various studies have examined the decreased ambulatory function of the TMA 
patient. Garbalosa, et. aI., 1996, examined kinematic data and plantar pressure of 14 
patients with diabetes and TMA (10). When measuring peak plantar pressures and 
comparing them to a control group, they found there were decreased pressures at the heel 
and increased pressures at the distal end of the residuum. The researchers felt that this 
may be due to the decreased dynamic dorsiflexion or increased plantar flexion in stance. 
Their kinematic data results showed decreased dynamic dorsiflexion motion throughout 
the gait cycle. It was suggested that the decreased use of available ROM throughout the 
gait cycle of the TMA group may be due to the decreased lever arm of the foot and a 
decreased ability of the plantarflexors to resist the forward motion of the tibia over the 
foot. 
While a decrease in dorsiflexion during stance was reported [9], Chrzan et. aI., 
1993, reported a conflicting increased knee flexion during stance. Increased knee flexion 
during stance corresponds with increased dorsiflexion due to the closed chain mechanism 
and need for upright posture. This study discussed joint motion and gait following TMA 
related to functionaldisruption of the long toe extensors and flexors, peroneus tertius, 
intrinsic muscles of the foot, and the plantar fascia (7). Equinovarus positioning is more 
common after TMA due to the imbalance ofmuscle strength and subsequent loss ofjoint 
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motion control. Gait initial contact occurs in a more inverted and less dorsiflexed 
position, followed by an irregular rollover. The stance is then finished with little or no 
push-off. The loss of the intrinsics and plantar fascia affect the integrity of the arches 
throughout stance and the dynamic stability provided by them during normal push-off. 
This predisposes the foot to future deformity. The muscular disruption following the 
TMA results in compensatory gait mechanics including a shorter stride length and a 
slower pace. 
Mueller and Sinacore, 1994, described two important rehabilitation considerations 
for the TMA patient: skin breakdown and imbalance. Because there is a high incidence 
of post-operative complications and re-ulcerations in this population, skin vitality is of 
primary concern. Other factors, such as peripheral neuropathy and the patient's medical 
history can adversely affect the balance ofthe TMA patient following the amputation. 
According to Mueller and Sinacore, this is due to the loss of available power generation 
ofthe plantarflexors with the shortened lever arm (11). As a result the researchers 
express the need for improved orthotic designs and rehabilitation. 
The ambulatory function of the TMA patient is decreased. Gait disturbances in 
the TMA patient are due to the functional loss of the skeletal lever arm and the imbalance 
of musculature. There is a loss of plantarflexion power generation required for push off 
and stability during stance. Balance is also adversely affected due to the smaller base of 
support provided by the shortened foot (6). 
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Peripheral Neuropathy Effects on Balance 
To complicate matters further, balance control of individuals with TMA due to 
diabetes mellitus and peripheral neuropathy is not only decreased with the smaller base of 
support, inadequate balance of musculature across joints and inability to generate power 
at the ankle, but the disparaging influence of peripheral neuropathy on balance is well 
established (12-23). Both decreased plantar sensation and decreased muscle activation 
appear to negatively affect balance control. 
Ducic et. aI., (2004), found a parallel relationship between balance and pedal 
sensations after evaluating sway in 35 patients with peripheral neuropathy using the 
MatScan Measurement System (12). As pedal sensations decrease, balance decreases. 
Uccioli et. al. (1995) evaluated 54 subjects with and without peripheral neuropathy under 
the age of 35 to remove the age related factor of increased body sway and found that the 
diabetic subjects with peripheral neuropathy had decreased control of postural balance 
control (13). In a more recent study, after evaluating 20 healthy subjects' EMG, 
kinematic and force plate data under 2 different conditions, normal and plantar surface of 
foot numbed with ice, Eils et al concluded that the reduced plantar sensation resulted in 
significant gait changes affecting the entire lower limb (21). Meier et al investigated the 
center of mass (COM) and center of pressure (COP) to determine balance control during 
gait termination. They found that the elderly diabetic neuropathic subjects adopted a 
'slowness strategy', but "despite the slower walking velocity, the AnteriorlPosterior and 
Medial/Lateral COP overshoots of the elderly Type II diabetic subjects are larger than in 
the elderly healthy subjects" (18). 
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In conclusion, patients diagnosed with diabetes mellitus with peripheral 
neuropathy have decreased balance control in weight bearing activities, increased 
compensatory mechanisms, and decreased ability to control changes to COM during gait 
transitions. Therefore it seems appropriate to also predict that diabetic patients with 
peripheral neuropathy and transmetatarsal amputation are predisposed to falls. 
Prosthetic/Orthotic Functional Studies 
Tang et. al. (2004) found improved temporal spatial parameters, and more 
normalized sagittal plane ankle angles, moments and powers with the use of a below­
ankle TMA orthosis as compared to no orthosis on eight individuals whose TMA was 
mostly due to trauma (24). The design of the TMA orthosis included a custom molded 
insole, toe filler and a full length Springlite carbon fiber plate of medium flexibility. 
Dillon and Barker (2006) evaluated COP excursion patterns of individuals with 
various levels of partial foot amputation while wearing their own orthoses. Replacement 
of the lever arm with an extended shank shoe modification was thought to be a simple 
remedy to the situation. However, Dillon's biomechanical analysis showed that the 
center of pressure does not progress beyond the distal end of the residuum when wearing 
(below-ankle) shoes or inserts fabricated to replace the rigid forefoot lever (25). 
Various studies have evaluated effects of ankle foot orthoses (AFO) on balance 
control for patients following a stroke or with cerebral palsy (26-30). We can compare 
the function of the AFO to the function ofthe partial foot orthosis. Mojica et. al. (1988) 
demonstrated that with the use of an AFO, there was decreased body sway and increased 
walking speed as compared to no AFO. The degree of balance control needed will 
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depend on each unique individual's functional needs, biomechanical alignment and 
muscle function. For instance, an individual with an upper motor neuron disease may 
likely exhibit extensor tone, which results in some inherent stance phase imbalance; 
whereas an individual with a lower motor neuron disease may have complete flaccidity, 
and therefore will require a different amount of support. There remains very little 
evidence on the stabilizing effects of orthoses and partial foot prostheses on individuals 
with peripheral neuropathies. 
Hirsch et. al. (1996) analyzed the vertical and antero-posterior ground reaction 
forces (GRF) of a below-ankle and a solid above-ankle design prosthesis on individuals 
after traumatic (non-diabetic) amputations. Comparisons between the amputated and 
non-amputated antero-posterior and vertical GRF differences were observed. Symmetry 
of the ground reaction forces improved with the use of the below-ankle prosthesis, but 
more so with the above-ankle design. Gait appeared smoother and more symmetrical 
with the above-ankle design. Two years following the study, participants were contacted 
and asked which prosthesis they preferred. None of them continued to use the above­
ankle design. There is a surprising discrepancy between the functional outcome and the 
patient's preference of the orthotic design, suggesting that there is a need to better 
understand and consider the functional demands during gait and the personal comfort of 
the amputee (31). 
Plantar Pressure Studies 
Neuropathy leads to biomechanical changes of the foot [43] with increases in 
peak plantar pressures which lead to increased susceptibility to plantar ulcers. Smith 
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found that patients with diabetic neuropathy and a history ofu1ceration had significantly 
greater plantar pressures (32), while Payne and Armstrong separately found dynamic 
plantar pressures to be higher in people with diabetes following partial foot amputation 
(33, 34). 
Plantar pressure can be directly altered with the use of insole material [31]. While 
using PPT under the metatarsal-phalangeal joints, the vertical plantar pressures were 
significantly reduced as compared to a barefoot condition. 
Plantar pressure can also be indirectly altered with the use of shoe modifications; 
such as various rocker sole modifications, specifically rocker bottom shoes have 
produced decreased plantar pressures in individuals (35) and forefoot relief shoes have 
been effective in reducing both mean and peak plantar pressures (36). 
Above-ankle devices have also been used in research to quantify differences in 
plantar pressure. Un-weighting of the plantar aspect of the foot and improved pressure 
distribution occurred with both the Aircast walking boot and total contact casting as 
compared to a standardized shoe in healthy individuals (37). The total contact cast 
healed a higher proportion of diabetic patients in a shorter period of time as compared to 
the Aircast fracture walker and the Darco half shoe (38), attributed to the direct total 
contact fit of the device. Lawless (2001) found reduced pressure under the first 
metatarsal head with the fracture walker and total contact cast as compared to barefoot; 
moreover, the fracture walker had a reduction in heel pressure as compared to the total 
contact cast (39). The authors attributed this to the heel rocker on the bottom of the 
fracture walker. 
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Above-ankle designs that stop dorsit1exion alter the GRF at terminal stance and 
allow the center of pressure to extend beyond the end of the residuum [36], but the affect 
on plantar in-shoe pressures has not been evaluated. Therefore, with ulceration occurring 
at the sites of peak plantar pressure, we propose to examine if indirect pressure re­
distribution occurs with the above-ankle device. 
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CHAPTER III 
RESEARCH DESIGN AND METHODS 
Subject Recruitment and Selection 
One group of subjects was evaluated to compare the balance characteristics 
between a below-ankle orthosis and an above-ankle limited motion orthosis both using 
rocker bottom shoes. Subjects were recruited from the community through contacts with 
local surgeons, podiatrists and orthotists/prosthetists. The participants included diabetic 
individuals with a fully healed transmetatarsal amputation and an ability to walk without 
an assistive device. Any person with a history of head trauma and other neurological 
impairment besides peripheral neuropathy were excluded from this study. This study has 
been approved by the University of Oregon IRB. 
Each subject filled out a preliminary questionnaire to determine age, height, 
weight, diabetes duration, date of amputation, eyesight (presence of retinopathy), self 
perceived activity level, whether or not they smoked, and if there was the presence of 
peripheral neuropathy, peripheral vascular disease, heart disease, or renal failure (40). 
They were assessed to determine the length of the residual limb compared to the 
uninvolved limb, the presence of contracture in sagittal or frontal planes, and strength. A 
physical examination included range ofmotion and strength assessment at the lower 
extremity joints, stance posture, and a timed up and go (TUG) balance score (see 
Appendix G). The TUG was chosen because it has been shown to be a reliable and valid 
test to predict functional mobility (41-48) as well as specific validity for physical 
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mobility of individuals with lower limb amputation (41). An age-matched non-diabetic 
control population were recruited and evaluated to attain baseline gait measurements for 
comparison. Finally, the patients were contacted 3-months after the collections to 
determine the patient's preference between the two devices using the Prosthetic Profile of 
Amputee Questionnaire. 
Design ofTMA Orthosis 
Each patient was seen by an orthotist/prosthetist (1) for casting, measurement and 
fitting of orthoses and shoes one month prior to each testing session to allow the subjects 
to 'break-into' the orthoses. Drew Shoes™ (Drew Shoe Corporation, Lancaster, OH) 
(Figure 7) were modified on the amputated side with a shank that extended to the toes to 
prevent the shoe from collapsing at the end of the residuum. The shoes are certified 
diabetic extra depth shoes. All shoes had rocker sole modifications with the apex of the 
rocker beginning just proximal to the location of the MTP of the shoe and sound side foot 
(6) (Figure 8). The sole modifications were identical between the involved and 
uninvolved limbs. 
Figure 7. Figure 8. 
Drew Shoe Rocker Sole Modification 
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Casting for the below-ankle orthosis was done with plaster holding the foot in 
subtalor neutral position while the patient sat. The total contact insole was fabricated with 
Plastizote™ (top layer), poron, a toe filler and a puff base to position the foot in a neutral 
position (if possible), to position the tibia vertical in both sagittal and frontal planes 
during quiet stance, and to provide total contact for distribution of plantar pressures 
(Figure 9). These materials were chosen for their accommodative properties. 
The custom below-ankle orthosis was placed on top of the above-ankle orthosis 
BlueRocker© (Allard USA, Rockaway, NJ) maintaining the same vertical alignment of 
the lower limb and the sagittal and frontal planes. The BlueRocker orthosis is a carbon 
fiber off-the-shelf limited motion AFO consisting of a full foot plate and a lateral strut 
extending to the anterior surface of the tibia (Figure 10). This design was used with all 
patients to maintain consistent treatment. 
All below-ankle orthoses were fabricated from the same materials, the lower legs 
were aligned to the same angles, and shoes were the same style and manufacturer to 
maintain continuity as these variables have been shown to affect the biomechanics of 
gait. Therefore, the only variable to consider was the addition of the AA orthosis. 
Figure 10. 
Figure 9. Blue Rocker 
Total Contact BA Orthosis AA Orthosis 
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Clinical Balance Examination 
The Timed-Up-and-Go test was given to compare the clinical measure to the 
motion analysis measure to determine distinguishing characteristics. This test has been 
shown to be a good predictor of fallers (43, 44) with a high re-test and inter-rater 
reliability (41,46,48). (See Patient Evaluation Form in the Appendix.) 
Gait Analysis 
The research took place in the Motion Analysis Laboratory, Department of 
Human Physiology, University of Oregon. Each subject was evaluated during two 
randomized visits over a period of one month. Gait evaluation included walking along a 
10-meter walkway on level ground during three conditions: without obstructions, and 
with obstructions at 2.5% and 10% of body height to simulate walking over a doorway 
threshold and over a curb (49). The obstacle was a 1" diameter PVC pipe positioned in 
the center of the walkway, between the two forceplates. Data collections of these 
conditions, again, was be randomized and subjects were allowed to rest between trials to 
reduce measurement of fatigue affects on gait. Subjects were instructed to walk at a self­
selected walking pace. 
Three-dimensional kinematic data was collected with an eight camera Motion 
Analysis System (Motion Analysis, Santa Rosa, Ca, USA) at 60 Hz. Body segments 
were defined using 29 passive markers arranged using 'Helen Hayes marker placement' 
as follows. Markers were be placed bilaterally at the tip of the acromion processes, 
lateral epicondyles of the humerus, centered between the dorsal side of the styloid 
processes ofthe radius and ulna, centered on the dorsum ofthe hands, both ASIS, lateral 
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femoral epicondyles, lateral malleoli, dorsum of the feet between the 2nd and 3rd 
metatarsals, posterior calcanei at the level of the foot markers. Thigh and shank wand 
markers were placed on the vertical line between the trochanter-lateral knee, and lateral 
knee-lateral malleolus, respectively. One marker was placed between the PSIS. Five 
markers defined the head and neck segment, one placed anteriorly centered above the 
brows, one posteriorly at the same level as the anterior marker, one at each temple and 
one on top of the head centered between the anterior/posterior and the medial/lateral 
markers. The final marker was placed on the right shoulder blade to define the right side 
ofthe body. (Figure 11) 
Figure 11. 
Marker Set 
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Kinetic data were collected with two dual AMTI force plates (AMTI, Newton, 
MA) to calculate instantaneous center of pressure (COP) data at 960 Hz and time­
synchronized to the kinematic data. 
Pressure Measurement 
Plantar pressure was measured separately from gait analysis. Both conditions 
(rocker soled shoes and above-ankle orthosis with shoes) were measured on the same day 
to increase reliability. Plantar pressure measurement was collected by a bipedal in-shoe 
F-Scan sensor system (Tekscan, South Boston, MA) at a sampling rate of 500 Hz with 
thin (0. 15mm), high resolution (4 sensels/cm2) disposable sensors. The sensors were 
taped on top of flat 1/8" insoles (Puff) so that movement of the sensors didn't change 
between the conditions. Flat insoling was used because the sensors do not conform well 
to the total contact custom insoles. The sensor tabs extended laterally up out of the shoes 
and connected into a cuff unit secured by a Velcro band around the ankles. Pressure 
information was sent via thin cables up to a remote transmitter that fitted around the 
waist. The mobile system required no cables to run from the subject to the computer 
therefore allowing more freedom of movement for the individual. 
Patient Satisfaction 
Three months after the data collections, all subjects were contacted via telephone 
to determine their satisfaction of the orthosis with a rocker bottom shoe. We understand 
that the device can only provide assistance if it is used by the patient. Improvements to 
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orthotic design need to include the patient's opinions about the level of perceived 
assistance and acceptance. The Prosthetic Profile of the Amputee Questionnaire has been 
shown to be valid and reliable (50, 51). 
Data Analysis 
Marker trajectory kinematic data were identified using EvaRT 4.4 (Motion 
Analysis, Santa Rosa, Ca, USA) and smoothed using a low-pass Butterworth filter (cutoff 
frequency = 8Hz). 
Figure 12 illustrates the gait events defined in Eva and labeled THS (trailing heel 
strike), LTO (leading toe off), etc. The red dot located between the two force plates is the 
obstacle at 10% of the subject's body height. The data between the first and last THS 
were cut, saved then processed using a custom algorithm written in Matlab. Using 
Dempster's anthropometric estimates of body segments (52) and a 13-segment model 
modified from Kadaba et al. and Jian et al. (53, 54), a 3-D COM of each segment was 
calculated. The partial foot and shoe as well as the shoe and foot on the sound side were 
assumed as one sum and calculated using the data of the foot. 
A weighted sum of these points was then used to define the whole body center of 
mass. Instantaneous COM-COP inclination angles were quantified as defined by Lee and 
Chou (55) as the angle formed between a vertical line passing through the COP and the 
line connecting the COM to the COP. Gait velocity was calculated at the whole body 
COM linear velocity, step width is the distance between the two ankle joint centers 
during heel strike and step length is the distance between the heel markers during heel 
strike to the same side heel marker at the next heel strike. 
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1. THS - trailing heel strike 2. LTO - leading toe off 
3. LHS - leading heel strike 4. TTO - trailing toe off 
•
 
6. LTO - leading toe off 
Figure 12. Gait Events 
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Statistical Analysis 
Between group (PF and control) differences in the anthropometric data and 
temporal-spatial data were assessed using independent t-tests using an alpha level of 0.05. 
The between-limb vertical GRF (vGRF) curves were analyzed using a 'goodness 
of fit' test called the Kuiper Test. Each subject's curves were analyzed separately due to 
the variability of clinical characteristics and conditions. We analyzed the difference 
between the involved and the uninvolved legs during the below-ankle and above-ankle 
conditions. The procedure is explained here: Five level gait conditions were collected 
with clean foot-strikes on the two separate forceplates. Each, vGRF graph was placed on 
a 100 point scale and the five trials were averaged resulting with one ensemble involved 
vGRF curve and one ensemble uninvolved vGRF curve. The'goodness of fit' between 
the involved and uninvolved vGRF curves was determined by finding the greatest vertical 
difference. If the Kuiper p-value under the null hypothesis of no difference between the 
two limbs was significant «0.05) the curves were determined to be statistically different. 
Kinematic and joint kinetic data were not analyzed as motion was observed 
between the foot and shoe. The foot and shoe were assumed to be a rigid body in our 
model. These data, therefore, were not considered valid. 
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CHAPTER IV 
RESULTS 
The purpose of this study was to evaluate the gait characteristics, specifically 
balance control and symmetry, while wearing an above-ankle orthosis compared to a 
below-ankle orthosis on individuals diagnosed with diabetes and transmetatarsal 
amputation (TMA). Plantar pressures were also evaluated between the two conditions as 
reducing peak pressure is one goal of the orthosis. Control subjects were included to 
obtain baseline values for comparison with our outcome measures. 
Subject Characteristics 
Six partial foot subjects (36) were evaluated and recruited having TMA (Table 1). 
These subjects, selected randomly, were male between the ages of 46-77yrs (57.7 ± 10.5 
yrs). The diabetes duration (8-43 yrs) and time since amputation (9 mo-18yrs) varied 
but were not related to the outcome measures. 
Table 1. Subject Anthropometries 
Age Ht Mass 
Limb (yrs) (m) (kg) 
PF1
 
PF2
 
PF3
 
PF4
 
R
R
L
R
 
54 1.76 82.5
 
46 1.94 143 
57 1.93 100 
59 1.80 117
 
PF5 Bi 53 1.84 115 
PF6
 L
 77 1.85 108
 
Average 
patient 
57.7 
57.2 ± 
1.85 
1.8 
110.9 
81.7± 10.6* 
Controls 9.5 ± 0.04 
average 
* Between group, p<O.05 
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The length difference between sound side and affected/amputated side shows the 
varying levels of TMA. One subject (PF5) had bilateral amputations during the 
collection. The control subjects (C) were age and gender matched. While their heights 
did not significantly differ from the PF subjects, their weights (81.7 ± 10.6) were 
significantly less than the PF patients (110.9 ± 20kgs), representative of the diabetic 
population. 
In order to bring the results of the study back to the clinical setting with the hope 
of using this as a pre-prescriptive analysis, each subject was assessed using the timed up 
and go (TUG) test while barefoot. All PF subjects had longer TUG times compared to C 
subjects (p=0.006) (Table 2). The duration oftime that the PF group was diagnosed with 
diabetes had a significant relationship with TUG (p=.045). PF3 had the greatest diabetes 
duration of 43 years diagnosed with type I when he was 14 years old, and the greatest 
TUG time (1 0.36sec). All subjects were being followed by their optometrists regularly 
and wore corrective lenses if necessary. 
Table 2. Subject Clinical Characteristics 
Time since Diabetes Presence of Diff TUG 
Amputation Duration retinopathy? (em) (sec) 
PFI 9 mo 25 yrs No 7 7.54 
PF2 3 yrs 8 yrs No 3.8 6.07 
PF3 4 yrs 43 yrs Yes 9.2 10.36 
PF4 3 yrs 8 yrs Yes 6.9 7.93 
PF5 18 yrs 15 yrs No 1.5 8.38 
PF6 13 mo 36 yrs No 10.9 9.05 
5.55 
Controls ± 1.12* 
Diff= sound side minus amputated side length discrepancy 
TUG=timed up and go balance test 
* Between group, p<O.05 
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Gait Temporal Distance Measures 
The gait temporal distance values did not change significantly between use of the 
below-ankle or above-ankle device, however there was a significant difference in gait 
velocities between the PF and control groups (Table 3) (Figure 13). Gait velocity of 
control subjects was greater than partial foot subjects gait veloCity during level and both 
obstacle crossing conditions. When stepping over the obstacle at 10% body height, all PF 
subjects had slower gait velocity during both orthotic conditions as compared to the 
controls (p < 0.002). 
Table 3. Temporal Distance Measures 
Gait Velocity Stride Length Step Width 
(m/s) IHeight (cm) IASIS (cm) 
Below Above Below Above Below Above 
Ankle Ankle Ankle Ankle Ankle Ankle 
PF Subjects 
Level 1.02 1.08 66.7 69.7 0.49 0.46 
2.5% Obstacle 0.96 1.01 70.5 72.5 0.48 0.49 
10% Obstacle 0.86 0.89 72.1 73.6 0.47 0.50 
Control
 
Level 1.47* 89 0.49
 
2.5% Obstacle 1.35* 91 0.48
 
10% Obstacle 1.23* 94 0.44
 
*Between group, p<0.05
 
Gait Velocity 10% Obstacle 
Control 
1.2~----------------------------------------· 
~ 1 
.!!!g 0.8 
~ 0.6 
u
'* 0.4 
> 0.2 
o 
PF1 PF2 PF3 PF4 PF5 PF6 
Figure 13. Gait Velocity SUbjects 
During 10% Obstacle Crossing ~w-Ankl~.-Above-Ank~: 
._---------, 
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Medial Inclination Angle - 10% Obstacle Crossing 
12 , 
Ul ~ 
Cl ~ 
10 
8 
:'-fj------­
o _LI 
-Jl- Control-----­
Balance Control During Gait 
No significant differences in gait were detected between the above-ankle and 
below-ankle devices. Only the subject PF3 had considerable improvement with the AFO 
as compared to the below-ankle condition; the medial COM-COP inclination angle 
reduced approximately 22% during the 10% obstacle clearance condition. No statistical 
difference was found in the peak medial COM velocities between orthotic conditions or 
between PF subjects and controls (Table 4) (Figure 14). 
Table 4. Balance Control Measures 
Medial Inclination Angle MIL Peak Velocity 
Below Above Below Above 
Ankle Ankle Ankle Ankle 
PF Subjects 
Level walking 5.90±0.95 5.85±0.97 0.17±0.04 0.18±0.04 
2.5% Obstacle 5.43±1.29 5.81±0.46 0.19±0.05 0.22±0.02 
10% Obstacle 6.11±1.40 6. 13±0.96 0.22±0.06 0.22±0.04 
Control 
Level walking 5.53±1.39 0.00±0.07 
2.5% Obstacle 5.30±1.44 0.04±0.08 
10% Obstacle 5.25±1.76 0.08±0.05 
PF1 PF2 PF3 PF4 PF5 PF6 
o Below -Ankle. Above-Ankle! 
Figure 14. Medial Inclination Angle 10% Obstacle Crossing 
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Symmetry 
The step lengths of the involved and uninvolved sides appeared to become more 
symmetrical with the use of the above-ankle device as seen in Table 5 and Figure 15. 
However, no statistical differences were found. 
Table 5. Step Length Symmetry 
Involved Uninvolved Uninvolved/Involved 
Step Length Step Length Step Length 
Below Above Below Above Below- Above-
Ankle Ankle Ankle Ankle Ankle Ankle 
PFI 75.59 71.144 67.805 67.478 0.90 0.95 
PF2 72.967 72.965 64.811 67.356 0.89 0.92 
PF3 64.74 63.992 62.914 65.137 0.97 1.02 
PF4 62.852 70.023 57.82 66.085 0.92 0.94 
PF5 52.372 56.441 56.207 62.539 0.93 0.90 
PF6 51.729 57.495 46.324 50.857 0.90 0.88 
Step Length Symmetry 
i 0 Below-Ankle I 
l- Pbove Ankle I 
PF1 PF2 PF3 PF4 PF5 PF6 
Subjects 
Figure 15. Step Length Symmetry Level Walking 
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Vertical ground reaction force (vGRF) curves are shown in Figures 16a-l, and the 
magnitude (x value) and timing (y value) ofthe two peak magnitudes occurring at early 
and late stance, respectively, are listed in Table 6 and 7. Differences in the peak force 
magnitudes and their corresponding times (% stance time) between the involved and 
uninvolved limbs during the two orthotic conditions were calculated. Statistical 
differences in the vGRF curves of the involved and uninvolved limbs were determined 
using the Kuiper EDF Test (Table 8). 
PF5 and PF6 appear to have improvements in the 'goodness offit' with the AA 
condition during early stance (Table 6). A significant between-limb difference in the 
vGRF curves was detected with the BA condition for subjects PF5 (Fig 16i, j) and PF6 
(Fig 16k, 1), (PF5: BE p=0.0019; AA p=0.2346) (PF6: BE p=0.0174; AA p=0.4984). 
A significant between-limb difference in the vGRF curves was detected with the 
AA condition for subjects PF1 (BA p=0.0574; AA p<O.OOOl) and PF2 (BE p=0.0606; 
AA p=0.0094) (Figures 16 a-d). This appears to be due to a greater difference in the 
peak vGRF magnitude of 45.4N and 35.0, respectively, during the late stance (Table 7). 
All but one of the PF subject's peak magnitudes occurred within 10% of each 
other when comparing the two orthotic conditions. PF6 had improved timing between 
the involved and uninvolved peak magnitudes during the AA condition, surprisingly 
during the first peak. Since there was so little similarity between the PF4 trials, the 
ensemble curves were not considered accurate and not included in this document (Figure 
16g and 16i). 
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Table 6. 1st Peak 
vGRF Inter-Limb Peak Force Magnitudes and Times 
% of stance time Peak Magnitude (N) 
Condition Involved Uninvolved Offset Involved Uninvolved Difference in Magnitude 
PFI BA 19 23 4 974.792 892.396 82.3956 
AA 19 26 7 984.881 896.108 88.773 
PF2 BA 27 21 6 1517.2 1677.91 -160.713 
AA 27 18 9 1512.07 1694.09 -182.016 
PF3 BA 20 25 5 1267.53 1173.03 94.4958 
AA 21 23 2 1121.72 1165.59 -43.8633 
PF4 BA 32 22 10 1087.26 1158.39 -71.1277 
AA 27 18 9 1158.11 1197.21 -39.1032 
PF5 BA 27 24 3 1306.25 1391.73 -85.4845** 
AA 23 24 1 1307.02 1268.88 38.1418** 
PF6 BA 22 34 12 1178.47 1138.94 39.5349* 
AA 26 26 0 1104 1127.68 -23.678* 
* p<0.05, ** p<O.OI, *** p<O.OOI 
Table 7. 2nd Peak 
vGRF Inter-Limb Peak Force Magnitudes and Times 
% of stance time Peak Magnitude (N) 
Difference in Condition Involved Uninvolved Offset Involved Uninvolved Magnitude
 
PFI BA 74 78 4 832.965 833.412 -0.4473***
 
AA 75 79 4 898.342 853.313 45.0287***
 
PF2 BA 77 76 1 1408.76 1449.16 -40.398** 
AA 77 73 4 1388.35 1463.37 -75.023** 
PF3 BA 73 68 5 929.37 933.57 -4.2084 
AA 66 73 7 888.02 924.27 -36.2516 
PF4 BA 73 71 3 1113.79 1118.58 -4.7885 
AA 75 75 0 1176.55 1136.76 39.7982 
PF5 BA 73 75 2 1069.81 1146.03 -76.2221 
AA 74 78 4 1083.04 1113.15 -30.1154 
PF6 BA 71 71 0 980.58 1035.6 -55.0105 
AA 67 64 3 997.12 1028.04 -30.922 
* p<0.05, ** p<O.O 1, *** p<O.OO 1 
Table 8. Kuiper Test (Asymptotic) 
(Pr > Ka) 
Subject PFI PF2 PF3 PF4 PF5 PF6 
Below 
Ankle 0.0574 0.0606 0.8945 0.5227 0.0019 0.0174 
Above 
Ankle <.0001 0.0094 0.0848 0.8487 0.2346 0.4984 
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Plantar Pressure 
The indirect effect of the above-ankle device on foot plantar pressures was 
examined using in-shoe plantar pressure sensors. Only 3 patients were able to participate 
in this part of the study due to medical conditions. The above-ankle device reduced the 
ankle motion in the sagittal plane (Table 9). The total ankle range of motion was 
reduced by approximately 10 degrees (with the use of the above ankle device with about 
4.5 fewer degrees of plantarflexion at foot strike and 5.2 fewer degrees of dorsiflexion at 
terminal stance.) 
Table 9. Tibial progression angle 
Maximum Minimum Maximum Minimum 
involved involved Total involved involved Total 
Below limb limb ROM Above limb limb ROM 
Ankle (36) (DF) Ankle (36) (DF) 
pf2 108.24 74.45 33.78 pf2 103.84 85.3 18.54 
pf4 107.36 79.42 27.94 pf4 104.05 82.26 21.79 
pf6 111.29 88.48 22.81 pf6 105.48 90.42 15.05 
Average 108.96 80.78 28.18 Average 104.46 86 18.46 
Table 10 shows the changes in the peak plantar pressure at the distal end ofthe 
foot during terminal stance. Peak plantar pressure occurred during terminal stance except 
for subject PF6 with the use of the above-ankle device. 
Table 10. Peak Pressure and Impulse at Distal End of Partial Foot 
PF2 
Peak Pre
Below 
Ankle 
96.65 
ssure (PSI) 
Above 
Ankle 
84 
Impulse 
Below 
Ankle 
82.08 
(kg*sec) 
Above 
Ankle 
81.2 
PF4 84.69 85.72 71.52 76.08 
PF6 96.68 64.76 65.45 30.23 
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The COP distance traveled varied between the two conditions. Stance phase 
displacement for PF6, as seen in Figure 17, illustrates the common pattern of motion 
during one below- and one above-ankle condition. The distance that the COP traveled 
decreased during the above-ankle condition as compared to the below-ankle condition by 
about one-third for PF2, one-quarter for PF4 and one-half for PF6 (p<O.OOI) (Table 11). 
Figure 17. Average COP Motion Level Walking (one trial) 
Table 11. COP Distance Traveled (mm) 
PF2 PF4 PF6
 
Below Ankle 7.86 ± 0.55 7.34 (0.60) 6.28 (0.20) 
Above Ankle 5:66 ± 0.27*** 5.24 ± 0.54 *** 3.37 ± 0.29*** 
***p<O.OOI 
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Patient Satisfaction 
The patients completed the Follow-up Questionnaire (Adapted from Prosthetic 
Profile of the Amputee - telephone version) as seen in the appendix. All patients felt at 
least moderately satisfied with the comfort, appearance, weight and the way they walked 
with the below-ankle (BA) orthosis. One subject was not satisfied with the appearance 
nor the gait with the above-ankle (AA) orthosis. Most subjects became quite well 
adapted to using the BA orthosis, while 3 of the 6 subjects were not at all adapted to the 
AA orthosis. All subjects stated that they were able to walk about a block and able to 
walk up and downstairs, but not without the use of a handrail. PF subjects varied in their 
use of the orthoses. Two of them preferred to walk around the house without the use of 
any device. Reasons that prevented the subjects from using the orthoses included 
difficulty in donning, the device being cumbersome, and greater comfort without the use 
of anything on their foot. All subjects felt more balanced with the use of the BA orthosis 
as compared to nothing. One subject felt less balanced with the use of the AA orthosis. 
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CHAPTER V 
DISCUSSION 
The six PF subjects included in this study varied in age, height and weight 
characteristics as well as their medical conditions. With either the above-ankle devie or 
the below-ankle device, all patients walked at a significantly slower gait velocity as 
compared to the control subjects. This agreed with the Timed-Up-and-Go scores, which 
showed a difference between the PF subjects and controls. When evaluating the PF 
subjects' between the below- and above-ankle conditions, no differences in velocity or 
other spatial temporal variables were observed for all three gait conditions -level, 2.5% 
and 10% obstacle crossing. 
Only one subject (PF3) demonstrated a 'noticeable balance improvement' with 
the AFO. The medial COM-COP inclination angle reduced approximately 22% with the 
use of the above-ankle orthosis. This subject also had the greatest TUG score. 
The TUG score may be proven to be an effective clinical exam. Those patients with 
greater TUG scores may have decreased functional mobility and a greater need for 
external support. The control medial inclination angles did not differ from most of the PF 
subjects, which was surprising. Inclusion of more control subjects could possibly make a 
difference as two of the control subjects had increased values compared to values 
measured in previous research. Walking with shoes, as compared to barefoot, may also 
have altered the values as compared to previous research, but does not explain why the 
control values were so closely matched to the partial foot subjects. There are a couple of 
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factors that may have affected this parameter. Trials where the subjects were not able to 
make two clean foot strikes on the forceplates were withdrawn. This altered the 
calculations because we only included the 'better' trials. Secondly, the task of stepping 
over an obstacle may not have been a differentiating enough task. 
Symmetry between involved and uninvolved limbs was evaluated using two 
different variables. Initially, we calculated the step length by dividing the uninvolved 
length by the involved length. Symmetrical step lengths should approach a ratio equaling 
one. Four of the six subjects step lengths approached more symmetrical values with the 
use of the above-ankle orthosis, similar to results shown by Tang et. al. (24). 
Our second variable used to evaluate symmetry was vertical ground reaction 
forces (vGRF) between the involved and uninvolved limbs. Hirsh et. al. (31) found 
improved symmetry in the vGRF with the use of above-ankle orthoses, although no 
statistical analysis was performed. We evaluated the two peak magnitudes (y-values) and 
the timing (x-value) when the peak magnitudes occurred over an average of five trials of 
level walking. The goodness of fit was calculated using the Kuiper Two-Sample 
Asymptotic Test. Our results were not consistent. Two PF subjects had statistically 
improved goodness of fit values comparing the involved and uninvolved limbs with the 
use of the above-ankle device, two subjects had decreased values, and two were 
unchanged. We hypothesized that the changes would occur during the second peak of the 
vGRF, but improvements in symmetry occurred during the first peak of the vGRF. The 
two subjects whose vGRF curves became less symmetrical had greater differences during 
the second peak (the push off phase of gait). The magnitude of the vGRF appeared be 
altered more by the above-ankle device than the percentage of the stance time when the 
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peak magnitude occurred. This analysis, though, should be interpreted with caution. PF4 
whose BA trials were extremely varied had an averaged curve with very little meaning. 
The AA vGRF curves appear more symmetrical but had no statistical difference between 
the conditions. This analysis requires further investigation. 
Only three PF subjects' plantar pressures were evaluated. One of the subject's 
data was lost due to equipment problems and two of the subjects had unrelated health 
issues that precluded them from coming back to the lab. Distal end plantar pressures and 
COP motion were measured using F-Scan in-shoe sensors. The AA device reduced ankle 
dorsiflexion, therefore reducing the tibial inclination angle during stance. Changes in 
peak plantar pressures at the distal end of the amputated foot varied between the subjects. 
Two of the subject's peak plantar pressures altered only slightly, however one subject had 
some indirect unloading from the distal end of the foot with the use of an AA device as 
compared to the BA device. This subject's distal peak plantar pressures decreased by 
about 30%, with a 50% decrease in the loading rate. The peak plantar pressures remained 
at the hindfoot while using the AA device throughout stance and unsurprisingly the 
distance that the COP traveled reduced the greatest amount (by about 50%). 
The COP in-shoe motion appears unrelated to the vGRF. All subjects COP 
motion decreased significantly with the use of the AA device. However, PF2 had an 
average of about 20N less force whereas PF6 had almost 20N greater force recorded 
during the second vGRF peak. These decreases in the excursion of the COP differ from 
Dillon's measures due to the methods used [24]. He used forceplates under the shoes to 
measure COP excursion and found that the COP actually traveled beyond the distal end 
of the residuum with the use of the AA devices. Both measures are important to consider 
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as in-shoe motion describes the direct contact between the foot and the shoe while the 
forceplate measures may be related to the vGRF curves and the kinetics of the lower 
extremities. 
Patient satisfaction may be one of the most critical parameters to examine to 
understand patient compliance and improve care. Optimally the prosthetic/orthotic 
design advantages should outweigh the disadvantages. Disadvantages and patient 
complaints of the above-ankle orthosis included the following: too cumbersome, too 
restrictive, difficult to don, and limited choice of shoe wear. Incidentally, most of the 
patients chose to wear the less bulky, lighter weight orthosis rather than the above-ankle 
design. Therefore, the subjects did not 'break-into' or get used to the function of the 
above-ankle design. Even if the above-ankle design may theoretically improve balance 
and symmetry, patient acceptance needs to be included to determine the appropriate 
device. Patient education, attitude and training also have an effect on their personal 
choice. Therefore, it is important that all clinicians involved in the amputee's 
rehabilitation communicate about the goals and work together as a team for consistent 
communications to the patient (56). 
The number one limitation common in all clinical practice with diabetic subjects 
was noncompliance - three subjects admitted that they did not wear the orthosis during 
the break-in time. Although, they "felt more natural while walking" with the use of the 
above-ankle device, they did not like the inability to move their ankles nor the tighter fit 
inside the shoe. 
Foot motion inside the shoe during the data collection is a second limitation. The 
foot and shoe were considered a rigid body in our model. The motion between the foot 
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and the shoe resulted in misleading angular motions and forces generated therefore 
limiting the variables we were able to examine in this study. 
A third limitation included in all studies examining subjects with chronic diseases 
is transient or brief 'ups and downs' in condition. One example of the fragile nature of 
prolonged diabetes includes PFI who was subsequently diagnosed with an intestinal 
cellulitis and placed on bedrest following the data collections. He underwent TMA on 
his previously unaffected side unrelated to his prosthetic fitting; he wasn't wearing the 
prosthesis while on bedrest. Six months later he is now walking and improving. Another 
example is PF4 who had extreme edema almost doubling the circumference of his legs. 
These complications alone appear to affect each individual's gait characteristics, 
regardless of the diagnosis of diabetes or amputation. It is difficult to determine how 
these conditions may have affected the subjects during the two different data collections. 
This study raised more questions: Does limiting the ankle medio-lateral motion 
eliminate the ankle strategy and increase demand from the hip strategy? This is 
illustrated by the increased step width and increased medial inclination angle. Dynamic 
ankle strategy has not been evaluated. Using an above-ankle device to limit ankle motion 
during gait may provide a useful evaluative tool to measure this. A second question arose: 
what are the most important clinical parameters to assess when deciding between a 
below- or above-ankle design? The TUG score may be a reliable measure but needs to be 
further investigated. Other questions for future study include, 'How joints interact with 
one another?', 'How does surgical technique affect outcome?', and finally, 'How does 
the orthosis affect energy expenditure?' 
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CHAPTER VI 
CONCLUSION 
Partial foot diabetic patients exhibit gait imbalance and asymmetries. Appropriate 
orthotic intervention is difficult to determine. Previous studies have demonstrated the 
functional impairments of TMA patients and expressed a need for improved orthotic 
designs and performance. This study evaluated the effectiveness of a low-profile AFO 
design in combination with rocker sole and custom insole to evaluate the effects on 
plantar pressure distribution, balance, symmetry and patient acceptance. 
Our results suggest that changes between the below- and above-ankle devices are 
individually specific. Only one subject (PF3) demonstrated a 'noticeable balance 
improvement' with the above-ankle device. This subject also had the greatest clinical 
Timed-Up-and-Go score. Most subjects had improved step length symmetry with the 
above-ankle design. Vertical GRF of the involved and uninvolved limbs were affected 
with the above-ankle device, but the results were not consistent. 
The first priority in diabetic care is protection from ulceration. The peak plantar 
pressures and loading rate, although not proven to be related to ulcer generation, reduced 
in only one PF subject. Mueller et al found that peak plantar pressure is most reduced 
with the use of an AFO, custom insert and rocker bottom sole, but reported patient 
complaints about the inability to move their ankles. Patient satisfaction of the above­
ankle device was low with similar complaints of difficulty in donning and discomfort due 
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to reduction in ankle motion. The benefits of the device must outweigh the disadvantages 
of wearing an orthosis. 
The fragile medical condition of this population warrants interdisciplinary 
teamwork and individually specific evaluations and treatments. It is difficult to draw 
conclusions from this study due to the small sample size and lack of patient compliance 
during the 'break in' schedule. There remains a need to find a comfortable, low-profile 
design that allows some ankle mobility but still provides strength and durability to 
support terminal stance. 
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APPENDIX A 
ABBREVIATIONS 
Diabetes Mellitus (DM)
 
Peripheral vascular disease (PVD)
 
Neuropathic disease (ND)
 
Transmetatarsal Amputation (TMA)
 
Range of Motion (57)
 
Center of Mass (COM)
 
Center of Pressure (COP)
 
Anterior/Posterior (AP)
 
Mediolateral (ML)
 
Ankle foot orthosis (AFO)
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DO Partial Foot Prosthetic Study 
Candidates Needed 
Effects of Below-Ankle Versus Above-Ankle
 
Partial Foot Prostheses on Gait Imbalance
 
This study aims to quantify variables to compare the effects of two different partial foot 
prostheses on individuals with partial foot amputation. We are looking at center of mass 
relative to center of pressure angles to determine changes in balance, if any. Other 
parameters include kinematic and kinetic data related to level walking and obstacle 
crossing as well as plantar pressure changes. The study is a single subject study. 
Who is conducting the study: 
Data collection: The University of Oregon, Motion Analysis Lab has an 
eight-camera motion analysis system (Motion Analysis Corp., Santa Rosa, CA) and data 
will be captured at a sampling rate of 60 Hz. Ground reaction forces will be collected by 
two force plates (Advanced Mechanical Technology, Inc., Watertown, MA) at a sampling 
frequency of 960 Hz. Plantar pressures will be measured with an in-shoe sensor system 
(Tekscan, South Boston, MA). 
Patients will be fitted by a certified Orthotist/Prosthetist at a local clinic with a 
below the ankle custom partial foot prosthesis fabricated with plastizote, poron, and a 
base of puff posted to neutral including a toe filler. Shoes will be fitted to sound side and 
partial foot prosthesis will be fitted to the shoe and foot. The shoes will be modified with 
rocker bottom soles. 
The above the ankle prosthesis will include the same below the ankle partial foot 
prosthesis fitted onto an AFO and fitted into the same shoes with rocker bottom soles. 
Inclusion criteria for patient sample include: 
• Ages 30-70 
.:. We would appreciate any 
• Diabetes mellitus 
assistance in finding • Healed transmetatarsal amputation 
individuals with partial foot • Ankle ROM within normal limits 
amputation due to diabetes. • Independent ambulation without an assistive 
device such as a cane or walker 
Exclusion criteria 
• No history ofhead trauma 
• No history of cerebrovascular accident 
Thank you for your time and your 
• No history of vestibular dysfunction 
contribution to our study. Please feel • No visual impairment uncorrectable by lenses 
free to contact us with any questions • No musculoskeletal diagnosis that could account 
or concerns. for imbalance. 
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AUTHORIZAnON FORM FOR RESEARCH DISCLOSURE
 
OF PERSONAL HEALTH INFORMATION
 
By my signature below,
 
I authorize ~D.P.M.IM.D./N.P.I Primary Care
 
Practitioner to release to Li-Shan Chou, Ph.D. and assistants to have access to the
 
following medical records:
 
_ Demographic information, including your name, address, phone number.
 
We will use the medical records containing your personal health information to study
 
patients' function with two different partial foot prostheses.
 
This authorization will expire at the end of the research study.
 
This authorization can be revoked at any time by delivering a revocation in writing to the
 
Health Care Provider named above and that the revocation will be effective except to the
 
extent (l) research has already been conducted in reliance on my previous authorization
 
or (58) if necessary to protect the integrity of the research (e.g., to account for a person's
 
withdrawal from the research).
 
I realize that Li-Shan Chou, Ph D. and assistants may not be bound by the Privacy Rule
 
and therefore may not be required by that Rule to maintain the confidentiality of my
 
personal health information.
 
The researchers can only use or disclose your health information for purposes approved
 
by the Institutional Review Board at the University of Oregon or as required by law or
 
regulations and will continue to protect your personally identifiable health information as
 
described in the attached Informed Consent Form. Data for each subject will be coded.
 
Only the principal investigator and graduate students directly involved in this project will
 
have access to information matching particular data sets to individual subjects.
 
I understand what this document says and authorizes release of my personal health
 
information as stated above. I understand I will be given a signed copy of this
 
Authorization for my records.
 
Signature of research participant Date 
Print Name 
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Dear 
You are invited to participate in a research study designed to gain a better 
understanding of balance and prosthetic designs for individuals with partial foot 
amputation. The study, conducted by the University of Oregon, Motion Analysis Lab, 
will provide information for the development of new and better prostheses. The title of 
the study is, Effects of Below-Ankle Versus Above-Ankle Partial Foot Prostheses on Gait 
Imbalance. 
Participants will be fitted by a certified Orthotist/Prosthetist at a local clinic with a 
partial-foot prosthesis and shoes. Here is a general timeline for the study: 
First appointment Appointment at orthotic/prosthetic facility for evaluation and 
measurement of prosthesis. 
2 weeks later Appointment at orthotic/prosthetic facility for fitting of shoes 
and prosthesis, shoes then need to be modified with rocker sole. 
1 week later Appointment at orthotic/prosthetic facility for follow-up and 
fitting of shoes. 
1 week later Appointment at University of Oregon Motion Analysis Lab for 
gait data collection. 
2-3 months later Appointment at the University of Oregon for second gait data 
collection. 
6 months later Phone call for final follow-up to ask your opinions of the 
prostheses. 
During both visits to the Motion Analysis Lab your body movement will be 
recorded during several walking trials. During some walking trials, you will be asked to 
cross an object with a height similar to a door threshold. In addition, strength of your hip, 
knee, and ankle muscles of both legs will be measured. You will be asked to wear a pair 
of paper physical therapy shorts and sleeveless shirt (tank top) during testing. 
No financial compensation will be provided. However, patients will receive the 
prosthesis and shoes with modifications at the completion of their participation. All 
information will be kept confidential. You must not have had any history of significant 
head trauma, neurological disorders, visual impairment not correctable with contact 
lenses or glasses, impairments related to bones, muscles and joints, or persistent 
symptoms of dizziness, lightheadedness, unsteadiness, or falling. 
Please feel free to contact us with any questions or concerns. If you wish to 
participate, please sign the attached form to release your name and contact information to 
the researcher, and you will be contacted about participating in the study. Thank you for 
your time and your contribution to our study. 
Li-Shan Chou, Ph.D. Sue Ewers, CPO, Graduate student 
University of Oregon University of Oregon 
Motion Analysis Lab Motion Analysis Lab 
541-346-3391 541-912-7614 
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Questionnaire
 
Please complete the following information to the best of your knowledge.
 
For Yes/No questions, please circle the appropriate response.
 
Age _
 
Height _
 
Weight _
 
Diabetes duration
 
Date of amputation _
 
Left or right foot: _
 
Eyesight
 
Presence of retinopathy Yes/No 
Do you wear glasses/contacts? Yes/No 
When did you last see your optometrist? _ 
Activity level 
Are you able to walk around inside your house? Yes/No 
Are you able to walk around outside your home? Yes/No 
What kind of work? 
How many hours/day are you on your feet? _ 
What kind of hobbies? 
Do you normally use an assistive device like a cane? Yes/No 
Do you feel unsteady when you walk? Yes/No 
Have you fallen since your amputation? Yes/No 
If so, when? _ 
Do you Smoke? Yes/No 
Do you have peripheral neuropathy? Yes/No 
Do you have peripheral vascular disease? Yes/No 
Do you have heart disease? Yes/No 
Do you have renal failure? Yes/No 
Do you check your feet regularly? Yes/No 
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Patient Evaluation 
Involved side: 
Length of residual limb % 
Length of uninvolved limb = 
ROM: Right Left 
Dorsiflexion ROM with knee bent 
Dorsifelxion ROM with knee straight 
Calcaneal inversion 
Calcaneal eversion 
Strength: Right Left 
Hip flexors 
Hip extensors 
Hip adductors 
Hip abductors 
Knee extensors 
Knee flexors 
Dorsiflexors 
Invertors 
Evertors 
Plantarflexors 
Stance posture: 
Photos 
Balance Test Scores: 
Timed up and go 
Instruction: stand up from a chair, walk 3 m (as quickly and as safely as possible without 
running), cross a line marked on the floor, tum around, walk back, and sit down 
-------
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TIMED UP AND GO BALANCE TEST
 
Balance Test 
Timed "Up & Go" Test (Posiadlo & Richardson, 1991) 
Instruction: stand up from a chair, walk 3 m (as quickly and as safely as possible without 
running), cross a line marked on the floor, tum around, walk back, and sit down 
Practice: TUG 
1. TUG Time
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PARTIAL FOOT INFORMED CONSENT 
Diabetic Partial Foot Prosthesis Study 
You are invited to participate in a research study, which will attempt to determine 
prosthetic fitting parameters for individuals with a partial foot amputation. The principal 
investigator, Li-Shan Chou, Ph. D., is a faculty member in Department of Human 
Physiology at the University of Oregon. You were selected as a possible participant in 
this study because we are specifically looking at partial foot amputees with diabetes who 
are active and able to walk without a cane or walker. 
If you decide to participate, you will be asked to engage in the following two data 
collections, one with a below-ankle prosthesis and the second with an above-ankle 
prosthesis. A 3-month follow up phone call will also be made to determine your 
satisfaction/dissatisfaction and comments regarding the prosthesis. Each data collection 
will take approximately 1 Y2 hours. All of the data collected is coded and therefore 
maintains all personal confidentiality. 
a.	 You will be asked to change into shorts and a tank top to allow joint 
landmarks to be identified. Medio-lateral dimensions of your thigh, leg and 
foot will be measured. Your weight and height will be recorded. This will 
take approximately 5 minutes to complete. 
b.	 A short manual muscle and range of motion exam will be performed along 
with a balance test. This should take no more than 20 minutes. 
c.	 Plantar pressure sensors will be placed inside of your shoes, on top of your 
insoles. These are thin (0.15mm) and are used to record the pressure 
distribution under your feet. These will provide information about how the 
pressure under your feet is distributed. We will also be able to, hopefully, see 
a change in how the pressure is distributed between the two different 
prostheses. 
d.	 Next, 35 reflective markers will be taped in place over bony landmarks on 
your upper and lower joints. These markers will be used to reflect 
information to 8 cameras for analysis of walking mechanics. You will be 
asked to perform three different activities. The first activity involves walking 
along a 20-foot walkway on level ground. The second activity involves 
walking along the same walkway over an obstacle. Finally the third activity 
involves walking and coming to an abrupt stop. The obstacle is similar in 
height to those ordinarily encountered during daily activities such as a door 
threshold. The obstacles will be two adjustable upright standards with a 
crossbar. The total time to complete these tests will be approximately 30 
minutes. 
-------------------
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There are some possible risks involved for the subject. This includes the possibility of 
mild muscle soreness after testing. However, the following safeguards will be used to 
eliminate or minimize these risks: 
- To minimize the possibility of residual muscle soreness, subjects will be 
provided ample time to warm-up their muscles and feel comfortable with 
the apparatus and testing protocol prior to the collection of any data. 
- An assistant will remain close to the subject at all times during testing to 
monitor subject comfort. Data collection will cease if the subject 
expresses discomfort. 
- There is a small risk that you may fall while walking over the obstacle. 
All information will be kept confidential. Computer data files, laboratory notes and 
videotapes will be archived in a locked filing cabinet. All records will be stored with a 
code number, not your name and will be kept by the principal investigator in the locked 
and security regulated Motion Analysis Laboratory. 
It is hoped that data from this study can assist in selecting appropriate prostheses as well 
as improvement in designs of prostheses. Upon completion of the test, you will be 
offered a copy of the test data, which you may share with your healthcare provider, if 
desired. 
Your participation in this study is entirely voluntary and your decision whether or not to 
participate will have no bearing on the medical treatment you receive or benefits to which 
you are otherwise entitled. If you decide to participate, you are free to discontinue 
participation at any time without penalty or loss of medical treatment or benefits to which 
you are otherwise entitled. There will be no change in the relationship, quality, current or 
future care with your medical professionals if you decide to withdraw from the study. 
If you have any questions about the research at any time, please call Li-Shan Chou, Ph.D., 
340 Gerlinger Annex, (541) 346-3391. If you have any questions about your rights as a 
participant in a research project; or in the event of a research related injury, please call the 
Human Subjects Compliance Office, University of Oregon (541) 346-2510. You will be 
offered a copy of this form to keep. 
Your signature below indicates that you have read and understand the information 
provided above, that you willingly agree to participate, that you may withdraw your 
consent at any time and discontinue participation at any time without penalty or loss of 
benefits to which you are otherwise entitled, that you will receive a copy of this form, and 
that you are not waiving any legal claims, rights or remedies. 
Print Name 
Signature Date _ 
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CONTROL INFORMED CONSENT 
Diabetic Partial Foot Prosthesis Study 
You are invited to participate in a research study, which will attempt to determine 
prosthetic fitting parameters for individuals with a partial foot amputation. The principal 
investigator, Li-Shan Chou, Ph.D., is a faculty member in Department of Hunian 
Physiology at the University of Oregon. You were selected as a possible control subject 
participant in this study because you have similar characteristics such as age, height and 
weight to other subjects in the study who will be fitted with two different types ofpartial 
foot prostheses. 
In order to be included in this study you must not have any of the following conditions: 
diabetes, neurological pathology, history of head trauma, history of cerebrovascular 
accident, history of vestibular dysfunction, visual impairment uncorrectable by lenses, 
musculoskeletal diagnosis that could account for imbalance. 
If you decide to participate, you will be asked to engage in the following activities during 
two separate data collection periods. Each data collection will take approximately I 'li 
hours. All of the data collected is coded and therefore maintains all personal 
confidentiality. 
e.	 You will be asked to change into shorts and a tank top to allow joint 
landmarks to be identified. Medio-Iateral dimensions of your thigh, leg and 
foot will be measured. Your weight and height will be recorded. This will 
take approximately 5 minutes to complete. 
f.	 A short manual muscle and range of motion exam will be performed along 
with a balance test. This should take no more than 20 minutes. 
g.	 Plantar pressure sensors will be placed inside of your shoes, on top of your 
insoles. These are thin (0. I5mm) and are used to record the pressure 
distribution under your feet. These will provide information about how the 
pressure under your feet is distributed. 
h.	 Next, 35 reflective markers will be taped in place over bony landmarks on 
your upper and lower joints. These markers will be used to reflect 
information to 8 cameras for analysis of walking mechanics. You will be 
asked to perform three different activities. The first activity involves walking 
along a 20-foot walkway on level ground. The second activity involves 
walking along the same walkway over an obstacle. Finally the third activity 
involves walking and coming to an abrupt stop. The obstacle is similar in 
height to those ordinarily encountered during daily activities such as a door 
threshold. The obstacles will be two adjustable upright standards with a 
crossbar. The total time to complete these tests will be approximately 30 
minutes. 
-------------------
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There are some possible risks involved for the subject. This includes the 
possibility of mild muscle soreness after testing. However, the following 
safeguards will be used to eliminate or minimize these risks: 
- To minimize the possibility of residual muscle soreness, subjects will be 
provided ample time to warm-up their muscles and feel comfortable with 
the apparatus and testing protocol prior to the collection of any data. 
- An assistants will remain close to the subject at all times during testing to 
monitor subject comfort. Data collection will cease if the subject 
expresses discomfort. 
- There is small risk that you may fall while walking over obstacles. 
All information will be kept confidential. Computer data files, laboratory notes and 
videotapes will be archived in a locked filing cabinet. All records will be stored with a 
code number, not your name and will be kept by the principal investigator in the locked 
and security regulated Motion Analysis Laboratory. 
It is hoped that data from this study can assist in selecting appropriate prostheses as well 
as improvement in designs of prostheses. Upon completion of the test, you will be 
offered a copy of the test data, which you may share with your physician, if desired. 
Your participation in this study in entirely voluntary and your decision whether or not to 
participate will have no bearing on the medical treatment you receive or benefits to which 
you are otherwise entitled. If you decide to participate, you are free to discontinue 
participation at any time without penalty or loss of medical treatment or benefits to which 
you are otherwise entitled. 
If you have any questions about the research at any time, please call Dr. Li Shan Chou, 
340 Gerlinger Annex, (541) 346-3391. If you have any questions about your rights as a 
participant in a research project, or in the event of a research related injury, please call the 
Human Subjects Compliance Office, University of Oregon (541) 346-2510. You will be 
offered a copy of this form to keep. 
Your signature below indicates that you have read and understand the information 
provided above, that you willingly agree to participate, that you may withdraw your 
consent at any time and discontinue participation at any time without penalty or loss of 
benefits to which you are otherwise entitled, that you will receive a copy of this form, and 
that you are not waiving any legal claims, rights or remedies. 
Print Name
Signature Date _ 
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Control Health History Questionnaire 
This brief questionnaire is used to verify some of the information discussed in the phone 
interview. If you answer yes to any question, and your current daily function is 
moderately or significantly impaired due to that condition, physician approval will be 
required for participation in the study. 
Print Name:	 Age: Height: Weight: _ 
Have you been under recent medical care for any of the following conditions? 
1. Diabetes?	 
---
Yes ___No 
2.	 Neurological disorder? Yes No 
If yes, is your daily function moderately or significantly impaired? 
3.	 A significant head injury? Yes No 
If yes, is your daily function moderately or significantly impaired? 
4.	 Heart disease or blood vessel disorder? Yes No 
If yes, is your daily function moderately or significantly impaired? 
5.	 Vision impairment that is uncorrected by glasses? Yes No 
If yes, is your daily function moderately or significantly impaired? 
6.	 Muscle, joint or other orthopedic disorder? Yes No 
If yes, is your daily function moderately or significantly impaired? 
7.	 Persistent vertigo, lightheadedness, unsteadiness, or falling?__Yes No 
If yes, is your daily function moderately or significantly impaired? 
Signature Date:
-----­
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Follow-up Questionnaire 
(Adapted from Prosthetic Profile of the Amputee - telephone version) 
The questionnaire contains about 10 questions. If needed do not hesitate to ask 
me to repeat any of the questions or choice answers anytime throughout the questionnaire. 
1. I will give you a choice of 5 answers to describe your satisfaction with respect 
to the comfort, the appearance and the weight of your orthosis, as well as your 
satisfaction regarding the appearance of your gait with your prosthesis. 
1=not at all satisfied
 
2=slightly satisfied
 
3=moderately satisfied
 
4=quite well satisfied
 
5=completely satisfied
 
a) with respect to the comfort of your prosthesis, would you say you are ... ? 
b) concerning the appearance (or the look) of your prosthesis, would you say you are ... ? 
c) concerning the weight of your prosthesis, would you say that you are ... ? 
d) and concerning the way you walk with the prosthesis(or the appearance of gait), 
would you say you are ... ? 
2. The question I am going to ask you now has to do with the ADAPTAnON (in 
the sense of "getting used to ... ") to your amputation and to your prosthesis. We know 
that this ADAPTATION can be more difficult for some people than for others and it is 
not always easy to evaluate. So, amongst a choice of 5 answers that I will read to you, 
choose the one which best describes your level of ADAPTATION TODAY. 
1=not at all adapted 
2=a little adapted 
3=moderatelyadapted 
4=quite well adapted 
5=completely adapted 
a) concerning your amputation, would you say that you are ... ? 
b) concerning your below-ankle prosthesis, would you say that you are ? 
c) concerning your above-ankle prosthesis, would you say that you are ? 
3. The next set of questions will be asked twice. There was a choice of four 
answers: 
1=no you are not able 
2=yes if someone helps you 
3=yes if someone is near you 
4=yes alone 
a) get up from a chair with your prosthesis 
b) pick up an object from the floor when you are standing with your prosthesis 
c) get up from the floor with your prosthesis (example: if you fell) 
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d) walk in the house 
e) walk outdoors on even ground 
f) walk outdoors uneven ground (on grass, gravel, slope... ) 
g) walk outdoors in inclement weather (snow, rain, ice) 
h) walk upstairs with handrail 
i) walk downstairs with handrail 
j) step up a sidewalk curb 
k) step down a sidewalk curb 
1) walk upstairs without handrail 
m) walk downstairs without handrail 
n) walk while carrying an object 
4. When you move about, approximately what percentage of your moving is done 0%, 
25%,50%, 75% or 100% 
a) in a wheelchair 
b) walking with the prosthesis 
c) walking without the prosthesis 
5. What prevents you from using the prosthesis. Answer 'yes or no'. 
a) is it because walking with the prosthesis is not fast enough 
b) because it is too tiring 
c) is it when distances to cover are too long 
d) is it because of problems with your non-amputated leg 
e) because of problems caused by the prosthesis 
f) because of stump problems (wounds) 
g) because you are afraid of falling 
h) is there another reason 
6. When walking with your prosthesis, approximately what distance can you cover 
without stopping? 
a) no limitations 
b) one block 
c) 30 steps 
d) between 10-30 steps 
e) less than 10 steps 
f) you do not walk 
7. Do you have to concentrate on every step you take when you walk with your 
prosthesis? 
8. Do you feel more or less balanced while using the below-ankle prosthesis? 
9. Do you feel more or less balanced while using the above-ankle prosthesis? 
10. Which do you feel improves your comfort while walking? 
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